作为预后和诊断标记,CDKN2A可能是肝细胞癌的关键贡献者
Jun Ding1, Ya-Ting Deng2,3, Yi Deng1
1Department of Hepatobiliary Surgery, Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Translational cancer research
|May 19, 2025
概括
循环素依赖性激酶抑制剂2A (CDKN2A) 在肝细胞癌 (HCC) 中被上调,与不良预后和瘤阶段相关. CDKN2A具有诊断价值,可能是HCC的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症基因组学 癌症基因组学
背景情况:
- 肝细胞癌 (HCC) 是一种致命的癌症,发病率和死亡率不断增加.
- 缺乏早期诊断标记物和有效的治疗点,阻碍了HCC治疗.
- 这项研究研究了循环素依赖性激酶抑制剂2A (CDKN2A) 作为HCC的潜在标记物和标.
研究的目的:
- 确定HCC的新诊断和治疗候选者.
- 确定CDKN2A在HCC中的表达特征.
- 评估CDKN2A的临床相关性,预后意义,诊断价值和表达调节.
主要方法:
- 分析了用于候选查的全转录组测序数据.
- 已经使用了TIMER 2.0,UCSC Xena,Kaplan-Meier,IHC,ESTIMATE,LinkedOmics,STRING和GeneMANIA,这些都是我们使用的.
- 评估了CDKN2A表达与临床病理指数和瘤免疫微环境的关联.
主要成果:
- 在HCC组织中,CDKN2A表达显著增加,与瘤大小和临床阶段相关.
- 高CDKN2A表达与预后不佳和瘤微环境的改变有关.
- CDKN2A对HCC具有明显的诊断价值,并且可以通过促进物甲基化来调节.
结论:
- CDKN2A显示出作为HCC的新型预后和诊断标记物的希望.
- CDKN2A代表了肝细胞癌的潜在治疗标.
- 对CDKN2A在细胞循环调节中的作用进行进一步的研究可以促进HCC治疗.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
7.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:15M-Cdk Drives Transition Into Mitosis
5.4K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.4K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K